SCHEMBL2599808

SCHEMBL2599808

CN(C)C(=O)NN=C(c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
NPSR1 Q6W5P4 2/20 0.55
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
BCHE P06276 1/20 0.47
FAAH O00519 1/20 0.47
MGLL Q99685 1/20 0.47
CTSL P07711 4/20 0.46
CTSK P43235 1/20 0.46
CTSB P07858 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
KDM4E B2RXH2 2/20 0.45
RECQL P46063 1/20 0.44
AGTR1 P30556 1/20 0.44
GSTA1 P08263 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2599774 0.84 MAPT (0.68) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL5998679 0.79 ALDH1A1 (0.61) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL14938501 0.78 ALDH1A1 (0.63) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL22649382 0.78 BCHE (0.64) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL2599809 0.77 LMNA (0.42) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL1562723 0.76 GSTA1 (0.68) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
Diphenylsemicarbazone SCHEMBL29448015 0.75 ALDH1A1 (0.67) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL6441842 0.74 ALDH1A1 (0.56) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL1562896 0.74 ALDH1A1 (0.75) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1
SCHEMBL1563600 0.74 ALDH1A1 (0.69) ALDH1A1NPSR1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403976-B2 Semicarbazones as accelerators for curing epoxy resins ALZCHEM AG (DE) 2016-08-02 US claimed
US-20130079488-A1 Semicarbazones as Accelerators for Curing Epoxy Resins ALZCHEM AG (DE) 2013-03-28 US claimed
EP-2571917-A1 SEMICARBAZONES AS ACCELERATORS FOR CURING EPOXY RESINS AlzChem AG (DE) 2013-03-27 EP claimed
WO-2011144659-A1 SEMICARBAZONES AS ACCELERATORS FOR CURING EPOXY RESINS ALZCHEM TROSTBERG GMBH (DE) 2011-11-24 WO claimed
EP-2571917-B1 SEMICARBAZONES AS ACCELERATORS FOR CURING EPOXY RESINS ALZCHEM AG (DE) 2016-12-07 EP disclosed
US-9403976-B2 Semicarbazones as accelerators for curing epoxy resins ALZCHEM AG (DE) 2016-08-02 US disclosed
US-20160083575-A1 Semicarbazones as accelerators for curing epoxy resins ALZCHEM AG (DE) 2016-03-24 US disclosed
WO-2015113930-A1 LIQUID CURING COMPOSITION FOR CURING POLYMER RESINS (I) ALZCHEM AG (DE) 2015-08-06 WO disclosed
US-20130079488-A1 Semicarbazones as Accelerators for Curing Epoxy Resins ALZCHEM AG (DE) 2013-03-28 US disclosed
EP-2571917-A1 SEMICARBAZONES AS ACCELERATORS FOR CURING EPOXY RESINS AlzChem AG (DE) 2013-03-27 EP disclosed
WO-2011144659-A1 SEMICARBAZONES AS ACCELERATORS FOR CURING EPOXY RESINS ALZCHEM TROSTBERG GMBH (DE) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079488-A1 Semicarbazones as Accelerators for Curing Epoxy Resins EP300, HDAC2, HDAC1 ALDH1A1 48/4885NPSR1 3602/4885RAB9A 4049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.